 |
|
Studies look at how genes affect antipsychotic drug response
November 10, 2006Researchers at the University of Illinois at Chicago College of Pharmacy are attempting to discover how genes determine how well an antipsychotic medication works in adults and children and the side effects it will cause.
Risperidone, a popular "atypical" antipsychotic medication, is used to treat mental illnesses such as schizophrenia and bipolar disorder.
Jeffrey Bishop, assistant professor of pharmacy practice, is examining the effects of one gene, catechol-o-methyltransferase, on brain activity, cognition and symptom response to the drug.
The study is being done in adults who are experiencing their first episode of schizophrenia who are treated with risperidone for six weeks as part of UIC's First Episode Program.
"Allowing patients with schizophrenia an increased chance at medication response literally could change their lives," Bishop said.
"While we know a great deal about the pharmacology of antipsychotics like risperidone, there is still much to learn about their influence on cognition and brain function, as well as how genetics affect overall medication response," he said.
Bishop says the project will serve as a first step toward a comprehensive pharmacogenetic analysis of metabolic pathways affecting response to the drug. He was presented with an award for new investigators from the American College of Clinical Pharmacy for the project.
The UIC Center for Cognitive Medicine's First Episode Program, directed by Dr. John Sweeney, has been studying patients with first-episode schizophrenia for the past five years.
Bishop is also beginning a second project to study how risperidone may elevate prolactin levels and cause weight gain in children ages 8-18 who suffer from pediatric bipolar disorder. An increase in prolactin (a pituitary hormone that may affect bone development) or weight gain occurs in some but not all of these young patients.
"We are trying to determine if some kids are at a greater risk than others for these problems by analyzing genetic markers," Bishop said.
Bishop said if children are to receive long-term drug therapy, clinicians need to make sure they are appropriately monitored and treated as safely as possible.
"Understanding risperidone pharmacogenetics and whether some individuals are at a higher risk for side effects is an important step in this process," he said.
Risperidone is widely prescribed to treat bipolar disorder in children, accounting for half of all atypical antipsychotic prescriptions in pediatric psychiatry. Adverse drug effects, such as weight gain and the possibility of prolactin elevation, are often dose-limiting and affect medication compliance.
University of Illinois at Chicago
The study is being done in adults who are experiencing their first episode of schizophrenia who are treated with risperidone for six weeks as part of UIC's First Episode Program.
"Allowing patients with schizophrenia an increased chance at medication response literally could change their lives," Bishop said.
"While we know a great deal about the pharmacology of antipsychotics like risperidone, there is still much to learn about their influence on cognition and brain function, as well as how genetics affect overall medication response," he said.
Bishop says the project will serve as a first step toward a comprehensive pharmacogenetic analysis of metabolic pathways affecting response to the drug. He was presented with an award for new investigators from the American College of Clinical Pharmacy for the project.
The UIC Center for Cognitive Medicine's First Episode Program, directed by Dr. John Sweeney, has been studying patients with first-episode schizophrenia for the past five years.
Bishop is also beginning a second project to study how risperidone may elevate prolactin levels and cause weight gain in children ages 8-18 who suffer from pediatric bipolar disorder. An increase in prolactin (a pituitary hormone that may affect bone development) or weight gain occurs in some but not all of these young patients.
"We are trying to determine if some kids are at a greater risk than others for these problems by analyzing genetic markers," Bishop said.
Bishop said if children are to receive long-term drug therapy, clinicians need to make sure they are appropriately monitored and treated as safely as possible.
"Understanding risperidone pharmacogenetics and whether some individuals are at a higher risk for side effects is an important step in this process," he said.
Risperidone is widely prescribed to treat bipolar disorder in children, accounting for half of all atypical antipsychotic prescriptions in pediatric psychiatry. Adverse drug effects, such as weight gain and the possibility of prolactin elevation, are often dose-limiting and affect medication compliance.
University of Illinois at Chicago
Antipsychotic Medication Current Events and Antipsychotic Medication News RSSEarly and network-oriented care may help adolescents at risk of developing psychosis
Family and network oriented, stress-reducing care improves level of overall functioning and mental health in adolescents at risk of developing psychosis, suggests a recent Finnish study.
Innappropriate drug prescriptions wasting millions, raising health risks
A recent study in Oregon suggests that drugs designed for treating the most severe mental illnesses are often prescribed at inappropriately low doses and at considerable expense, for use in conditions where their benefit has not been established.
Antipsychotic drugs double risk of death among Alzheimer's patients
New research into the effects of antipsychotic drugs commonly prescribed to Alzheimer's patients concludes that the medication nearly doubles risk of death over three years.
Risks and benefits of antipsychotics in children and adolescents
Many of the psychiatric disorders observed in adults have their onset in childhood or adolescence. In fact some studies show that at least 20% of children and adolescents will fulfil a diagnostic criterion for a mental disorder before reaching adulthood.
Violence declines with medication use in some with schizophrenia
Some schizophrenia patients become less prone to violence when taking medication, but those with a history of childhood conduct problems continue to pose a higher risk even with treatment, according to a new study by researchers at Duke University Medical Center.
Short-term use of antipsychotics in older adults with dementia linked to serious adverse events
Older adults with dementia who receive short-term courses of antipsychotic medications are more likely to be hospitalized or die than those who do not take the drugs, according to a report in the May 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Restrictive drug policies often cause schizophrenic patients to discontinue medication
Policies requiring authorization before physicians can prescribe newer medications to schizophrenic patients may be counter-productive. According to a new study, patients in Maine's Medicaid program who found themselves in this situation were 29% more likely to stop or disrupt medication use than patients not subject to the policy.
Weight gain induced by antipsychotic drugs can be avoided
A research team from Université Laval's Faculty of Medicine and Robert-Giffard Hospital has demonstrated that weight gain induced by the use of antipsychotic drugs-which in extreme cases can be as high as 30 kilos in only one month-can be avoided through a specially designed weight control program.
Diabetes medication and lifestyle changes can help treat weight gain induced by antipsychotic drugs
Lifestyle intervention and the drug metformin are both effective against antipsychotic-induced weight gain, and treatment is most effective when the two therapies are combined, according to a study in the January 9/16 issue of JAMA.
Blood pressure drug curbs brain damage from PTSD
A drug used to treat high blood pressure and enlargement of the prostate may protect the brain from damage caused by post-traumatic stress disorder, Alzheimer's disease, depression and schizophrenia.
More Antipsychotic Medication Current Events and Antipsychotic Medication News Articles
 |
Breakthroughs in Antipsychotic Medications: A Guide for Consumers, Families, and Clinicians. by Ronald J. Diamond (Author), Ruth Ross (Author), Patricia L. Scheifler (Author), Peter J. Weiden (Author), Ronald I. Diamond (Author) From the National Alliance for the Mentally Ill, this book gives consumers, their families, and clinicians information about antipsychotics that have recently become available. For people with schizophrenia and other psychotic disorders, antipsychotic medications are the key to recovery. Yet older medications have serious side effects and rarely affect symptoms like lethargy. New antipsychotics have advantages, but they are not for everyone, if only because of their cost. This book helps consumers and their families weigh the pros and cons of switching medications and guides them through the process of switching. For clinicians, it includes technical details on the new medications and their side effects. |
 |
The Effects Of Anti-Psychotic Medication Forced Upon The Unfortunate Souls Who May Or May Not Need T Lafcadio (Primary Contributor) |
 |
Dosing Antipsychotic Medications: Insights From Data and Practice - A Video Symposium Also With: William Glazer M.D. (Primary Contributor), Peter J. Weiden M.D. (Primary Contributor), Dan L. Zimbroff M.D. (Primary Contributor) Dosing is often the key to establishing efficacy and minimizing side effects of atypical antipsychotics. Tailoring medication dose to severity of illness and phase of illness allows clinicians to meet individual patient needs. Clinical experience regarding dosing may differ from data collected during clinical trials. The PsychLink experts will merge the insights gleaned from clinical trials with the lessons learned from clinical practice to outline optimal dosing strategies of atypical antipsychotics. |
|
Metabolic effects associated with atypical antipsychotic medications.(The Art of Prescribing): An article from: Perspectives in Psychiatric Care by Deborah Antai-Otong (Author) This digital document is an article from Perspectives in Psychiatric Care, published by Nursecom, Inc. on April 1, 2004. The length of the article is 1874 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Metabolic effects associated with atypical antipsychotic medications.(The Art of Prescribing) Author: Deborah Antai-Otong Publication: Perspectives in Psychiatric Care (Refereed) Date: April 1, 2004 Publisher: Nursecom, Inc. Volume: 40 Issue: 2 Page: 70(3) Distributed by Thomson... | |
![Sharing decisions in consultations involving anti-psychotic medication: A qualitative study of psychiatrists' experiences [An article from: Social Science & Medicine]](http://ecx.images-amazon.com/images/I/519EPRSDSHL._SL160_.jpg) |
Sharing decisions in consultations involving anti-psychotic medication: A qualitative study of psychiatrists' experiences [An article from: Social Science & Medicine] by C. Seale (Author), R. Chaplin (Author), P. Lelliott (Author), A. Quirk (Author) This digital document is a journal article from Social Science & Medicine, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser. Description: In psychiatry, and in treating people with a diagnosis of schizophrenia in particular, there are obstacles to achieving concordant, shared decision making and in building a co-operative therapeutic alliance where mutual honesty is the norm. Studies of people with a diagnosis of schizophrenia have revealed critical views of medical authority, particularly over the issue of enforced compliance with antipsychotic medication. Psychiatrists are known to place particular value on such medication. This qualitative... |
|
Primer for prescription medications: the first long-acting atypical antipsychotic.(RX Primer): An article from: Annals of the American Psychotherapy Association by Harpriya A. Bhagar (Author), Alan D. Schmetzer (Author) This digital document is an article from Annals of the American Psychotherapy Association, published by Thomson Gale on December 22, 2005. The length of the article is 1381 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Primer for prescription medications: the first long-acting atypical antipsychotic.(RX Primer) Author: Harpriya A. Bhagar Publication: Annals of the American Psychotherapy Association (Magazine/Journal) Date: December 22, 2005 Publisher: Thomson Gale Volume: 8 Issue: 4 Page: 28(1) Distributed by Thomson... | |
|
Principles of switching novel antipsychotic medications.(The Art of Prescribing)(Column): An article from: Perspectives in Psychiatric Care by Deborah Antai-Otong (Author) This digital document is an article from Perspectives in Psychiatric Care, published by Nursecom, Inc. on January 1, 2005. The length of the article is 1528 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Principles of switching novel antipsychotic medications.(The Art of Prescribing)(Column) Author: Deborah Antai-Otong Publication: Perspectives in Psychiatric Care (Refereed) Date: January 1, 2005 Publisher: Nursecom, Inc. Volume: 41 Issue: 1 Page: 45(3) Article Type: Column Distributed by Thomson... | |
|
Primer for Prescription Medications: the antipsychotic medicines--atypical.: An article from: Annals of the American Psychotherapy Association by Alan D. Schmetzer (Author) This digital document is an article from Annals of the American Psychotherapy Association, published by American Psychotherapy Association on September 1, 2002. The length of the article is 1516 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Primer for Prescription Medications: the antipsychotic medicines--atypical. Author: Alan D. Schmetzer Publication: Annals of the American Psychotherapy Association (Refereed) Date: September 1, 2002 Publisher: American Psychotherapy Association Volume: 5 Issue: 5 Page: 26(2) Distributed by Thomson... | |
|
Reconsidering psychiatric drugs.(Health)(The role of anti-psychotic medications comes under scrutiny): An article from: The Register-Guard (Eugene, OR) by Gale Reference Team (Author) This digital document is an article from The Register-Guard (Eugene, OR), published by Thomson Gale on January 28, 2007. The length of the article is 2197 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Reconsidering psychiatric drugs.(Health)(The role of anti-psychotic medications comes under scrutiny) Author: Gale Reference Team Publication: The Register-Guard (Eugene, OR) (Newspaper) Date: January 28, 2007 Publisher: Thomson Gale Page: A1 Distributed by Thomson... | |
 |
The Effects Of Anti-Psychotic Medication Forced Upon The Unfortunate Souls Who May Or May Not Need Them Lafcadio (Primary Contributor) |
| © 2009 BrightSurf.com |